TRAC and neoplasm: In 2017, Liu et al. [468] used CRISPR/Cas9 technology to knock out TRCA (encoding the endogenous TCRα subunit) and B2M (encoding an essential subunit of the MHC-I molecule) in T cells, producing universal CAR-T cells that greatly reduced tumor growth in mouse models.